piracetam has been researched along with naloxone in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Wade, JP | 1 |
| Chellingsworth, MC; Kendall, MJ; Main, AN | 1 |
| Endröczi, E; Korányi, L | 1 |
| Dukhanin, AS; Iasnetsov, VV; Krylov, IN; Pal'tsev, IuP | 1 |
| Bollengier, F; Engelborghs, S; Finné, E; Matton, A; Vanhaeist, L | 1 |
| Biber, B; Björklund, U; Block, L; Hansson, E; Jörneberg, P; Westerlund, A | 1 |
2 review(s) available for piracetam and naloxone
| Article | Year |
|---|---|
Multi-infarct dementia: prevention and treatment.
Topics: Cerebrovascular Disorders; Dementia, Multi-Infarct; Dihydroergotoxine; Humans; Hypertension; Naloxone; Piracetam; Pyrrolidines | 1991 |
Therapeutic progress--review XVIII Alzheimer's disease.
Topics: Alzheimer Disease; Cerebrovascular Circulation; Cholinesterase Inhibitors; Humans; Nafronyl; Naloxone; Neurotransmitter Agents; Parasympathomimetics; Peptides; Piracetam; Psychotherapy; Vasodilator Agents | 1985 |
6 other study(ies) available for piracetam and naloxone
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Piracetam modifies morphine and related drug-induced elevation of serum corticosterone concentration in rats.
Topics: Animals; Corticosterone; Female; Hypothalamo-Hypophyseal System; Morphine; Nalorphine; Naloxone; Piracetam; Pituitary-Adrenal System; Pyrrolidinones; Rats; Stimulation, Chemical | 1983 |
[Pharmacologic correction of learning and memory disorders induced by exposure to high-frequency electromagnetic radiation].
Topics: Animals; Learning Disabilities; Male; Memory Disorders; Microwaves; Naloxone; Piracetam; Psychotropic Drugs; Pyrrolidines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Cholinergic; Receptors, GABA-A; Receptors, Opioid | 1993 |
Modulating effect of the nootropic drug, piracetam on stress- and subsequent morphine-induced prolactin secretion in male rats.
Topics: Animals; Dose-Response Relationship, Drug; Drug Tolerance; Immobilization; Male; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Nootropic Agents; Piracetam; Prolactin; Rats; Rats, Wistar; Stress, Psychological | 1996 |
A new concept affecting restoration of inflammation-reactive astrocytes.
Topics: Actins; Analgesics, Opioid; Animals; Astrocytes; Calcium Signaling; Capillaries; Coculture Techniques; Cytokines; Cytoskeleton; Endothelial Cells; Glutamic Acid; Inflammation; Interleukin-1beta; Levetiracetam; Lipopolysaccharides; Male; Naloxone; Narcotic Antagonists; Nootropic Agents; Oligopeptides; Piracetam; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase | 2013 |